6th Swiss Industrial Chemistry Symposium, SICS 2026
| Start Date | 30.01.2026 - 08:30 |
| Event End | 30.01.2026 - 17:00 |
| Location | Biozentrum, Lecture Hall U1.131 |
Website and registration
https://sics26.scg.ch
Deadlines
Registration is closed and we are fully booked.
Registration Fees
Free of charge for SCS members
100 CHF for non-SCS members
Chair
Stefan Hildbrand, F. Hoffmann-La Roche Ltd.
___________________
Program
08.30 Registration and morning coffee
09.00 Welcome Message
Session 1 - Chair: Dr. Hayley Binch, F. Hoffmann-La Roche Ltd
09.15 Dr. Henrik Moebitz, Novartis
SCS Senior Industrial Science Award Lecture 2025
«Adventures in chemical space»
09.45 Dr. Fides Benfatti and Dr. Federico Dapiaggi, Syngenta
«Target-Based Design and Hit to Lead Optimization of Pyrimidinylpyrazole Insecticides»
10.15 Coffee Break
Session 2 - Chair: Dr. René Wyler, Novartis Pharma AG
10.45 Dr. Lorena de Luca, Givaudan
«AmbreXolideTM: Synthesis via Olefin Metathesis»
11.15 Dr. Rafael Bermeo Malo, and Dr. John Lopez, Novartis
«FXX489 – A FAP targeting ligand with best-in-class potential for Radioligand Therapy»
11.45 Dr. Lionel Saudan, dsm-firmenich
«Hydrogenation and Hydroformylation Reactions for the Synthesis of New Perfumery Ingredients»
12.15 Lunch Break
Poster Session: max. 50 posters will be accepted. Abstract submission until Dec 15, 2025
Exhibition and Networking
Session 3 - Chair: Dr. Sarah Sulzer, Syngenta Crop Protection AG
14.00 Dr. Thomas Debnar, Siegfried
«Sustainability by Process Design – Development of a 3-Step Domino-Sequence en route to buprenorphine»
14.20 Dr. Michal Shoshan, metaLead Therapeutics AG
«Short peptides as next-generation chelating agents for treating Wilson disease»
14.40 Dr. Alessandro Castrogiovanni and Dr. Francesca Militano, Merk
«An end-to-end robotic platform for high-throughput formulation development of biologics»
15.00 Dr. Irene Malpartida, Deasyl
«Mechanochemical Synthesis and Production Scale-up for Glycerol Valorisation Products»
15.20 Dr. Trung Cao, Cilag
«Driving Sustainability in the API Early Development Space»
15.40 Coffee Break
Session 4 - Chair: Dr. Stefan Abele, Pharvaris GmbH
16.10 Dr. Dominique Roberge, Lonza
«Innovative Journey to Continuous-Flow Industrialization»
16.40 Dr. Daniel Hunziker and Dr. Serena Fantasia, Roche
«Discovery and process development of Mosperafenib: the next-generation brain permeable, paradox breaker BRAF inhibitor»
17.10 Ceremony Best Presentation Awards
3x 2min pitches of the winners
17.30 Aperitif and networking